GSE123828
XmaI-RRBS on Luminal B breast carcinoma samples taken prior to chemotherapy
Luminal B breast carcinoma samples were taken prior to chemotherapy in order to identify epigenomic profiles predictive of neoadjuvant chemotherapy efficacy Overall design: Reduced representation bisulfite sequencing by XmaI-RRBS (Tanas et al., 2017)